Renamezin

· Daewon Pharmaceutical Co., Ltd.

Drug timelines are a Plus or Pro feature.

2 regulatory and trial events tracked for Renamezin, covering 2017-07-06 to 2017-07-06. Get the full timeline:

Most recent: Clinical Trial Update: Phase Ⅳ Clinical Trial to Evaluate of Renamezin in Patients With Chronic Renal Failure. [Phase 4]